Issuu

A. SECTION

Artwork by: Jordan Lovegrove, Ngarrindjeri Artist of Dreamtime Creative, Tiaki Terekia of Ngāti Kōhuru and Margaret Aull of Te Rarawa, Tūwharetoa and Fijian descent

The RCPA acknowledges the Traditional Owners of Country throughout Australia and recognises their continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander traditions and cultures, and to Elders past, present and emerging.

2 RCPA Annual Report 2025-2026

The RCPA acknowledges the rangatiratanga of Māori as tangata whenua and Treaty of Waitangi partners in Aotearoa New Zealand.

Contents From the President

From the CEO

RCPA year in review

Celebrating 70 years of the RCPA

Training and assessment

Policy and advocacy

RCPA projects

Membership and engagement

In recognition

3 Return to contents

From the President Prof Sandra O’Toole, RCPA President

The past year has been significant for the Royal College of Pathologists of Australasia (RCPA) – a year of celebration, progress, challenge and renewal. Our 70th anniversary provided an opportunity to reflect on seven decades of leadership in pathology and healthcare across Australasia, and on the contribution of generations of Fellows who have shaped the College and our profession. It also prompted us to consider what is needed to ensure pathology continues to meet the changing needs of patients, clinicians and health systems.

Delivering on our strategic priorities The College’s 2024–2027 Strategic Plan continues to guide our work (see page 7). During the year, we made progress across these priorities in training, advocacy and member engagement, including: Pathology funding. The Government’s reintroduction of indexation for selected pathology items on the Medicare Benefits Schedule (MBS) was a welcome first step towards addressing the longstanding erosion of pathology funding (see page 18). The College will continue to advocate for indexation across the full schedule to support the sustainability of pathology services. Genetic pathology. The recognition of genetic pathology as a new medical specialty – the first new medical specialty recognised in Australia in 15 years (see page 15). This is an important milestone for pathology and reflects the growing role of genetics and genomics in modern healthcare. Cultural safety. The College continued its work to strengthen cultural safety across pathology training and professional practice, working with Aboriginal and Torres Strait Islander and Māori partners, including ABSTARR and the Australian Indigenous Doctors’ Association (AIDA). This important work reflects the College’s commitment to supporting culturally safe healthcare and a more inclusive profession (see page 16). Examinations. A comprehensive review of examinations with the Australian Council for Educational Research (ACER) is in progress to strengthen the validity and consistency of assessment and ensure our examination system remains rigorous, sustainable and fit for the future (see page 17). As we approach the final year of the current Strategic Plan, the appointment of Dr Louise Wienholt as CEO marks an important new chapter for the College. Work will begin on developing the next Strategic Plan from 2027, providing an opportunity to build on what we have achieved and set a clear direction for the years ahead. 4 RCPA Annual Report 2025-2026

Advocacy that makes a difference Workforce sustainability remains a critical priority. The College’s workforce review continues to provide an important evidence base for advocating for the specialist workforce needed to meet future demand and maintain access to high-quality pathology services. We also achieved important progress through the Medical Services Advisory Committee (MSAC) process, helping to ensure decisions about pathology testing are informed by evidence, clinical utility and patient need. Our advocacy extends beyond funding to workforce sustainability, access to pathology services, emerging technologies and the future of pathology across Australasia. Through this work, we continue to champion the essential role of pathology in healthcare.

Change and transformation 2026 has also been a year of organisational change. Change brings challenges, but it also creates an opportunity to consider how we work, how we engage with our members and how we can strengthen the College for the future. My priority as President has been to foster a College that is transparent, inclusive and accountable, built on integrity and where members and staff feel valued, respected and heard – a College we can all be proud of.

Thank you I am deeply grateful to our members for the expertise, time and commitment they contribute to the College through all areas of our work, including examinations, training, accreditation, committees, professional standards and advocacy. This contribution is fundamental to the College and to the quality of pathology across Australasia. I also acknowledge Dr Paul McKenzie for his leadership as Interim CEO during a demanding period of transition. I look forward to working with Louise, the Board, our staff and the Fellowship as we shape the College’s next chapter. The strength of the RCPA has always been its people, its expertise and its commitment to pathology. As we begin our eighth decade, our challenge is to harness those strengths with ambition and purpose – ensuring the College remains a strong voice for the profession and that pathology continues to deliver the highest standards of care for the communities we serve.

Prof Sandra O’Toole RCPA President

Meet the Board

Prof Sandra O’Toole President

A/Prof Chris Hemmings Vice President

A/Prof Diane Kenwright Vice President New Zealand

Prof Noel Woodford Secretary/Treasurer

A/Prof Robert Bird Chair of the Board of Education and Assessment

Dr Cameron Snell Chair of the Board of Professional Practice and Quality

Prof Caitlin Keighley AC Chairs Representative

Dr Kim Cheah Council Representative

Dr Nicole Sladden State and Regional Representative 5 Return to contents

From the CEO

Dr Paul McKenzie, Interim RCPA CEO

Following the resignation of Dr David Andrews, I was privileged to serve as Interim CEO from February to June 2026. I would like to acknowledge David’s contribution to the College and thank him for his service. 2026 has been a year of significant change for the College. Global uncertainty, a slowing economy and increasing costs have created financial headwinds, while significant staff changes have required the organisation to adapt. Despite these challenges, the College has maintained its full range of services for members and continued to deliver across its core areas of training, professional standards, advocacy and member engagement.

Strengthening our organisation Strengthening financial management has been an important priority during the year. Our financial systems have continued to be modernised, with improvements to budgeting and forecasting supporting stronger financial oversight and governance. Together with the College’s sound financial reserves, this provides a strong foundation for the years ahead. We have also strengthened our internal capability through the appointment of a part-time People and Culture Business Partner, bringing this function in-house following the use of external human resources contractors. Urgent remediation work was also undertaken on the College’s buildings during the year, with a focus on ensuring the safety of staff and visitors and protecting the financial and heritage value of these important assets.

Investing in our future The College’s digital transformation program has continued, with work progressing on a new customer relationship management system, website and learning management system. These projects represent a significant investment in the College’s future and will streamline internal processes, improve access to information and services, and enhance the experience for Fellows, Trainees and other users. The coming year will be an important period as these systems move towards implementation and become embedded in the way the College operates.

6 RCPA Annual Report 2025-2026

The comprehensive review of the College’s examinations, undertaken with the Australian Council for Educational Research (ACER), has also reached an important milestone. The ACER report has been received and its recommendations will guide changes to strengthen the validity and consistency of assessment, reduce duplication and support a more consistent approach across disciplines. Implementation will be a key area of work in the coming year, in consultation with Fellows, examiners, Trainees and the Boards responsible for training and assessment.

Our volunteers The College relies on the extraordinary voluntary contribution of our Fellows and Faculty Fellows across almost every aspect of the College’s work, including committees, examinations, training and professional standards. I join the President in extending my personal thanks to everyone who has contributed during the year. Your generosity, knowledge and commitment are fundamental to the College’s ability to serve the profession and the wider community.

The next chapter As I conclude my term as Interim CEO, I warmly welcome Dr Louise Wienholt as the College’s new CEO. Louise brings extensive experience across pathology, health service management and quality systems, as well as fresh perspectives for the next stage of the College’s development. After a long career in pathology, I have valued the opportunity to contribute to the College in a different capacity at an important point in its history. I wish Dr Wienholt, staff and all our members every success for the future. I am confident the College has the expertise, commitment and strong foundations needed to continue its important work and support high standards of pathology and healthcare across Australasia.

Dr Paul McKenzie Interim RCPA CEO

RCPA Strategic Plan 2024–2027 Workforce We will enhance our existing plans and develop new strategic initiatives to effect sustainable growth and ongoing support for the pathology workforce.

Education and continuing professional development (CPD) We advance the profession of pathology by delivering high-quality, effective training programs for Fellows and Trainees and by supporting our Fellows and members in their CPD activities.

Standards We lead pathology in Australasia by supporting, developing, monitoring and maintaining evidence-based and quality-focused standards in pathology.

Advocacy and awareness We engage with governments, industry and other stakeholders in pathology to effect change and raise awareness.

Member support and communication We ensure that Fellows, Trainees and other members are effectively served by the College throughout their career and wherever they are located.

Our communities and the future We are committed to high-quality, equitable pathology services that are equipped to deliver safe and comprehensive care for our diverse communities.

Organisational resilience We ensure the College’s resilience through our inclusive and supportive culture, effective planning, governance, resourcing and investment in our people and processes.

For more information, read the full RCPA Strategic Plan 2024-2027: rcpa.me/StrategicPlan

7 Return to contents

2. RCPA YEAR IN REVIEW

Member snapshot 128

3150

RCPA Fellows

RCPA New Fellows

Fellows and Trainees by discipline

491

836

RCPA Faculty Fellows and Trainees

RCPA Trainees

351 154

Fellows by discipline 31

962

Trainees by discipline

60 87

386

149

36 Anatomical pathology (1351)

258

Chemical pathology (149) Forensic pathology (87) General pathology (60)

17 13 2

Genetic pathology (36) Haematology (962) Immunopathology (154) Microbiology (351)

8 RCPA Annual Report 2025-2026

1351

Members by country 3.5% 0.5%

148

111

Other

117

78%

2470 291

Australia

New Zealand

Malaysia

Singapore

49%

Hong Kong

Other

Fellow breakdown by gender

Male

44%

Female

Trainee breakdown by gender

Male

During the year, the Faculties progressed education and training initiatives, supported members and contributed to the ongoing development of their fields of practice.

56% Female

Faculties The College’s Faculties continue to support specialist practice, education and professional development across their respective disciplines.

51%

32 58

491

Faculty Fellows and Trainees

Faculty of Science (363) Faculty of Clinical Forensic Medicine (58) Faculty of Oral and Maxilofacial Pathology (32) Faculty of Post-mortem Imaging (38)

363 9 Return to contents

2. RCPA YEAR IN REVIEW

Financial snapshot Income and expenses RCPA income

1% 3%

Membership fees (40%)

10%

Training registration fees (14%) Examination fees (13%)

RCPA income

16%

40%

Events (16%) Investments (10%) Pathology journal (3%) Donations – RCPA Foundation (1%)

13%

Other (3%)

14%

$14,917,005 Total income

RCPA expenses 7%

Employment (42%) Conferences and education (18%)

Professional fees (11%) Travel and accommodation (6%)

Grants (3%)

RCPA expenses

Information technology systems upgrade (8%) Other (7%) Administration and operating costs (5%)

$17,124,020

11% 18%

Total expenses

RCPA Profit/Loss -$2,207,015 10 RCPA Annual Report 2025-2026

42%

3. CELEBRATING 70 YEARS OF THE RCPA

70 years of the RCPA Celebrating 70 years of pathology leadership With 2026 marking the RCPA’s 70th anniversary since incorporation, the College commemorated this historical milestone with celebrations both in person and online. Focusing on the contributions of members, the celebrations reflected on how the RCPA came to be, the achievements in diagnostic medicine over the years, and opportunities for the future.

Platinum refresh

Pathology Update 2026

Members may have noticed a refresh of our logo earlier in 2026, with a special platinum edition featured on the website, email signatures and other assets to commemorate the 70th anniversary.

The in-person celebrations kicked off at Pathology Update 2026 in Sydney, with a special 70th anniversary dinner following the graduation and awards ceremony. Complete with a slide show and photo booth, the event was an opportunity to recognise the vital contributions of members to the College and the pathology profession – and to have some fun!

11 Return to contents

70 A. SECTION

YEARS

1967

1959 First President,

First edition of Pathology journal, to be published quarterly

Dr Edgar Thomson

1956

College of Pathologists of Australia incorporated 10 April 1956

1966

First Councillor for New Zealand approved

1970

Regional Committee set up for New Zealand

HM Queen Elizabeth II granted the College the privilege of using the title ‘Royal’

Celebrating the risk takers and history makers As part of the RCPA’s 70 year anniversary, we celebrated leaders in pathology and related sciences who paved the way to the formation of the College, and those who have trailblazed since the RCPA’s incorporation in 1956. These individuals pushed boundaries, challenged systems and asked ‘what if?’

Dr Elaine Marjory Little (1884-1974) Dr Little completed her residency in Sydney during WW1, but as a woman, she was barred from joining the Australian Army Medical Corps. Determined, she travelled to London and became a Royal Army Medical Corps Captain, researching fatal influenza in British Army hospitals. Returning home, she established herself as a consulting haematologist at Sydney Hospital and Royal North Shore Hospital, and became one of the few female founding Fellows of the RACP. Dr Little went on to become a founding Fellow of the College of Pathologists of Australia (now the RCPA). 12 RCPA Annual Report 2025-2026

Defining firsts in the history of the RCPA

1995

First female President of the College, Dr Eva Raik, appointed

1979

College name changed to Royal College of Pathologists of Australasia

2000

Meritorious Service Award created to honour service given to the College

1999

2001 RCPA held its first ASM in Hong Kong, later known as Pathology Update

First CEO, Dr Debra Graves, appointed

Prof John Robin Warren AC (1937-2024) It was during Prof Warren’s time as a staff specialist in pathology at Royal Perth Hospital that he observed bacteria in stomach sections associated with peptic ulcers. Working with Prof Barry Marshall, Prof Warren was able to demonstrate that bacteria was the causative agent. This revolutionary discovery, initially rejected by the medical fraternity as it was understood that bacteria was unable to grow in the stomach, finally led to a cure for peptic ulcers. The Australian duo went on to receive many great honours, including the Nobel Prize for Medicine in 2005.

Prof Richard Scolyer AO (1966-2026) Prof Richard Scolyer AO was an internationally renowned anatomical pathologist whose pioneering contributions to melanoma diagnosis, classification and translational research helped transform the understanding and treatment of this disease. Recognised as joint Australian of the Year in 2024, Richard was also a dedicated mentor, educator and advocate for pathology. Following his diagnosis with glioblastoma in 2023, he demonstrated extraordinary courage and generosity in openly sharing his personal journey, raising awareness of brain cancer and advocating for research and innovation in treatment. His remarkable contributions to medicine, his compassion and his determination to improve the lives of patients leave an enduring legacy for the pathology profession and the wider community. Return to contents

4. TRAINING AND ASSESSMENT

Training and assessment The RCPA’s training and assessment team delivered a significant program of work over the past year, navigating regulatory reform, advancing implementation of Australian Medical Council (AMC) standards, progressing assessment reform and preparing for the introduction of a new College customer relationship management (CRM) system and website. The College continues to deliver a substantial and growing program of specialist training and assessment. Across more than 39 programs, certificates and modules, we have supported around 820 Trainees, and we welcome around 158 new Trainees each year. During the reporting period, 149 Fellows were conferred, contributing to the specialist pathology workforce.

We delivered more than 80 examination types across Australia, Aotearoa New Zealand, Hong Kong, Malaysia, Singapore and Brunei, accounting for more than 1569 examination sittings annually. Our focus has been to ensure that training and assessment programs remain high quality, contemporary, sustainable and responsive to the needs of Fellows, Trainees and the profession.

New Fellowships attained in 2025/26

12 Faculty of Science by Research 9 Microbiology 8 Chemical pathology 8 Immunopathology 6 Forensic pathology of Science 5 Faculty by Examination 4 Genetic pathology of Science by 2 Faculty Scientific Achievement of Clinical 1 Faculty Forensic Medicine 14 RCPA Annual Report 2025-2026

Anatomical pathology

Haematology

Faculty of Science by Pathology Informatics

2026 Basic Pathological Sciences (BPS) Examination The 2026 Basic Pathological Sciences (BPS) examination was delivered online to 417 candidates. This marked the fourth consecutive year in which more than 400 candidates sat the examination. The College continued its initiative to waive examination fees for first-time candidates who identify as Aboriginal, Torres Strait Islander or Māori. In 2026, candidates included three Aboriginal or Torres Strait Islander people, four Māori and one Pacific person.

Overview of BPS candidates

417 157 187 73

BPS candidates

Medical students

Non-Trainee doctors Trainees

For the first time, all RCPA Trainees who sat the BPS passed the exam.

Genetic pathology recognised as a new field of specialty practice Following the Australian Health Ministers’ approval of genetic pathology as a new field of specialty practice in June 2025 – the first new field of specialty practice to be approved for inclusion on the national list in 15 years – the College completed the final steps towards accreditation. A significant milestone was achieved in February 2026, when the Australian Medical Council (AMC) accredited the College’s Genetic Pathology training program. This establishes an approved specialist qualification for future genetic pathologists and enables approximately 50 existing Fellows to apply for specialist registration in genetic pathology. From 22 October 2026, only medical practitioners with specialist registration in genetic pathology will be permitted to use the protected title ‘specialist genetic pathologist’.

15 Return to contents

A. SECTION

Insert main heading RCPA welcomed around 149 new Fellows to the specialtist medical workforce at the 2025 Fellowship and Awards Ceremony.

Australian Medical Council (AMC) Accreditation Standards

Cultural safety and Indigenous health

The College’s specialist medical training programs continue to be accredited under the 2023 Australian Medical Council (AMC) standards. During the year, the College also contributed to the AMC’s review of accreditation standards for specialist medical programs.

During the year, the College undertook a significant review of cultural safety, Indigenous participation and health equity across its specialist medical training system.

Following the anticipated publication of revised standards in late 2026, the College will begin preparations for full program accreditation ahead of its scheduled accreditation in March 2028. The AMC has also introduced Model Standards for Specialist Medical College Accreditation of Training Settings, aimed at improving consistency and transparency across specialist medical colleges. Through the newly established Training Setting Accreditation Committee, the College has progressed implementation of the new requirements and remains on track to meet the February 2027 deadline. The revised standards place increased emphasis on: transparency and procedural fairness workplace culture and Trainee wellbeing cultural safety and equity risk-based accreditation outcome-based training. 16 RCPA Annual Report 2025-2026

In May 2026, the College engaged ABSTARR to conduct an independent assessment of how cultural safety and Aboriginal and Torres Strait Islander health, Māori health and health equity are embedded across the RCPA’s curricula, assessment and training systems. The review found that the College has established a strong foundation for embedding these principles across its specialist training programs, while also identifying opportunities to strengthen their integration across curriculum design, assessment, supervision, accreditation and organisational governance. The findings will inform the development of a practical action plan to guide future work and support the College’s ongoing readiness for AMC accreditation.

4. TRAINING AND ASSESSMENT

Strengthening standards in pathology training and assessment The College has progressed a comprehensive review of its examinations and associated assessment processes in partnership with the Australian Council for Educational Research (ACER). During the year, ACER completed its review and presented its findings to Fellows, Trainees, supervisors and examiners through a series of information sessions. The recommendations provide a framework for strengthening the College’s assessment system across four key areas: assessment design and blueprinting standard setting and scoring examiner professional development governance and quality assurance. Together, the recommendations will support greater consistency, fairness and educational value across the College’s assessment processes.

Certificate in Surgical Pathology Dissection The Certificate in Surgical Pathology Dissection was established to provide a structured training pathway for laboratory scientists and other appropriately qualified professionals undertaking surgical pathology dissection. Applications for the first intake opened in July 2025, attracting 77 applications and associated requests for training determinations. Of these, 43 candidates accepted a training determination and commenced the pathway. Fourteen candidates are undertaking training in Aotearoa New Zealand, including one Trainee who identifies as Māori, with the remaining candidates based in Australia.

The next phase will involve detailed consideration of the recommendations and implementation planning, supported by a working group with member representation.

Streamlining the pathway for Specialist International Medical Graduates The College has actively contributed to national consultation on the implementation of Recommendation 12 of the Kruk Review, which seeks to streamline the assessment of Specialist International Medical Graduates (SIMGs) and reduce unnecessary duplication within the specialist pathway. The College’s SIMG assessment team has been closely involved in the consultation process as Ahpra and the Medical Board of Australia progress this work.

12 43

Curriculum reviews The College undertakes comprehensive curriculum reviews on a five-year cycle to ensure its training programs remain contemporary, relevant and aligned with evolving professional practice. During the year, the immunopathology curriculum was reviewed for implementation in 2026. Reviews of the forensic pathology and microbiology curricula, along with the Molecular Pathology Certification Modules in microbiology, are underway and scheduled for implementation in 2027.

Specialist International Medical Graduates attained Fellowship Specialist international medical graduate assessments (30 Australia and 13 New Zealand)

17 Return to contents

5. POLICY AND ADVOCACY

Policy and advocacy Strengthening the College’s influence During 2025–26, RCPA continued to strengthen its policy and advocacy capability, building the systems, evidence and relationships needed for a credible and strategic presence across Australia and Aotearoa New Zealand. The College worked to ensure the expertise of Fellows, Trainees, Faculties and committees informed decisions affecting workforce, training, diagnostic funding, regulation, digital health and the future delivery of pathology services. Specifically, we focused on translating clinical and professional expertise into practical policy positions and solutions for governments, regulators and health agencies.

Building a sustainable pathology workforce Workforce sustainability remained a major advocacy priority. The RCPA remained actively engaged in the Australian Government’s review and redesign of the Specialist Training Program (STP), which funds around 20% of pathology Trainees. With the redesigned program expected to place greater emphasis on regional, rural and remote, and Aboriginal and Torres Strait Islander training priorities, the College advocated to ensure pathology was not unintentionally disadvantaged. Unlike many patient-facing specialties, pathology services for regional and remote communities are frequently delivered through larger metropolitan laboratories. Pathology training also requires access to a sufficient case mix, specialist supervision and laboratory infrastructure, which cannot always be provided entirely within a single regional site. The RCPA therefore advocated for a program design that supports equitable training distribution. The College also commenced a national data-collection project to strengthen the evidence base on workforce shortages by jurisdiction and pathology specialty, supporting future workforce modelling and the case for sustainable workforce and training investment.

18 RCPA Annual Report 2025-2026

This evidence-led approach was reflected in the College’s 2026–27 Federal pre-Budget submission on genetic pathology, which called for a A$13.9 million investment over five years to fund 17 additional genetic pathology training positions. The proposal highlighted the critical role of genetic pathologists in cancer care, rare disease diagnosis, precision medicine and the broader national genomics agenda.

Workforce sustainability remained a major advocacy priority. The RCPA remained actively engaged in the Australian Government’s review and redesign of the Specialist Training Program (STP), which funds around 20% of pathology Trainees.”

Supporting access to contemporary diagnostic testing The RCPA continued to expand its work through the Medical Services Advisory Committee (MSAC) pathway, progressing a growing pipeline of applications seeking public funding for new and amended pathology services. In July 2025, the College piloted a new process for prioritising member-nominated MSAC applications. Proposals were assessed consistently against clinical need and utility, evidence readiness, budget impact, equity of access, feasibility and alignment with national priorities, with the process shaped through member feedback. Two RCPA-led applications considered by MSAC in April 2026 achieved positive outcomes. MSAC supported

public funding for POLE genotyping for the molecular classification of endometrial cancer. It also supported key components of the College’s application for ADAMTS13 testing for thrombotic thrombocytopenic purpura, including diagnostic and genetic testing, while not supporting testing for ongoing monitoring during remission. Further College applications continued to progress through the MSAC pathway across genomics, cancer, haematology and other areas of diagnostic testing. This work helps to ensure public funding can keep pace with advances in diagnostic technology, clinical practice and patient care.

Bringing pathology expertise to major health-system reforms The College continued to provide specialist advice on major reforms affecting pathology practice, clinical governance and patient safety. As part of the RCPA’s sustained engagement on the release of pathology results through My Health Record, the College supported greater patient access to health information while raising concerns about implementation arrangements for complex, sensitive or potentially lifechanging diagnoses. Working with affected pathology disciplines, RCPA translated clinical concerns into practical implementation advice and engaged closely with the Australian Digital Health Agency and the Australian Government Department of Health. This advocacy secured additional implementation time for anatomical pathology, cytopathology, genetics and specialised haematology, allowing further work on the clinical, technical and patient-safety issues associated with these results. The College contributed multidisciplinary expertise to the development of the new National Pathology Standard, which is intended to consolidate and modernise core requirements within the NPAAC pathology accreditation framework. The new Standard brings together requirements previously addressed across several separate NPAAC accreditation documents.

The RCPA’s feedback addressed issues including governance, accountability, genomics, artificial intelligence and digital interoperability, helping to ensure the pathology profession had a strong voice in shaping the future accreditation framework for laboratories and pathology services. The College has played an active role in the Australian Medical Council’s (AMC’s) review of accreditation standards for specialist medical programs, advocating for a more outcomes focused and proportionate approach. Through detailed submissions and engagement with the AMC, the RCPA has worked to ensure future standards support quality training while recognising the diversity and practical realities of specialist medical colleges. The College also commenced advocacy to modernise Commonwealth Medicare requirements that currently prevent routine Medicare-funded pathology reporting from home or other non-accredited locations. The proposed reform would better align the law with contemporary pathology practice, supporting workforce flexibility, specialist access, service resilience and retention while maintaining existing accreditation, quality and patient-safety safeguards.

19 Return to contents

5. POLICY AND ADVOCACY

NZ ASM 2025 at the Beehive in Wellington.

Advancing advocacy in Aotearoa New Zealand The College strengthened its advocacy presence in New Zealand during 2025–26, with a dedicated New Zealand Policy and Advocacy Manager commencing in August 2025. The New Zealand Committee subsequently endorsed the College’s first dedicated New Zealand Advocacy Strategy, establishing three priorities: securing the pathology workforce seeking strategic diagnostic investment improving equity and efficiency through appropriate funding and testing. Workforce in the region remained a major focus. The RCPA engaged extensively with Health New Zealand on pathology registrar training and presented a validated, ready-to-implement workforce solution to the Finance and Expenditure Select Committee and Minister of Health. Although additional registrar positions were not funded through Budget 2026, pathology workforce investment remained a central advocacy priority. The College also advocated for pathology to be recognised in the New Zealand Government’s NZ$65 million Diagnostic Improvement Plan after pathology

20 RCPA Annual Report 2025-2026

had initially been excluded despite the expected increase in scans and procedures. The RCPA’s analysis estimated that this diagnostic activity could generate approximately 7330 additional anatomical pathology cases in the first year alone, highlighting the need for investment in diagnostic activity to be supported by sufficient laboratory capacity. As a result of this advocacy, in February 2026, Health New Zealand formally acknowledged they had underestimated the requirements and identified several pathology services where the impacts of the plan would be more than minor. They confirmed they had allocated budget to support those services to respond to the impacts. The College also broadened its relationships across government and the health sector, establishing new connections and maintaining regular engagement with Health New Zealand, the Ministry of Health, the Ministry of Justice, the Pathology National Clinical Network and the Council of Medical Colleges. This relationshipbuilding was accompanied by submissions on the New Zealand Budget Policy Statement, physician associate regulation, cultural competence and cultural safety standards, and scope of practice reviews. Together, this engagement is laying the groundwork for stronger and more sustained pathology influence in New Zealand.

Responding to emerging models of diagnostic care Rapid changes in how consumers access testing were another focus during the year. The College provided detailed advice to the Therapeutic Goods Administration (TGA) on chlamydia and gonorrhoea self-test kits, raising concerns about diagnostic limitations, clinical and public health oversight, validation transparency, post-market surveillance and consumer guidance. In June 2026, the TGA suspended the TouchBio Chlamydia & Gonorrhoea Test for Self-testing from the Australian Register of Therapeutic Goods for six months after identifying performance concerns, including potential false-negative results. The regulatory action was consistent with risks previously raised by the College. The RCPA also engaged with NSW Health on reforms concerning direct-to-consumer and telehealth-ordered testing, supporting stronger public health protections while emphasising the need for clear professional boundaries and safeguards against pathologists inadvertently being assigned responsibility for broader clinical management.

As self-testing becomes increasingly common in Australia, the College published a profession-wide position statement to help shape this rapidly evolving area. The statement establishes principles for safe and effective self-testing while advocating for stronger safeguards around higher-risk tests where misinterpretation, delayed care or inappropriate treatment decisions could cause harm. By providing a clear framework for an emerging model of diagnostic care, the College is helping to ensure patient safety remains at the centre of diagnostic innovation. The RCPA also worked with the Human Genetics Society of Australasia to develop new guidance supporting the appropriate use of medical genetic testing by nurse practitioners and endorsed midwives. Developed in response to changes to national requirements, the guidance supports safe, high-quality patient care by helping to ensure genetic testing is requested, interpreted and acted on appropriately within an increasingly complex healthcare environment.

Increasing member participation and visibility Member expertise continued to underpin the College’s advocacy The new MSAC prioritisation process incorporated member feedback in determining future public-funding priorities. In New Zealand, member consultation also informed advocacy priorities. In the College’s member advocacy survey, 43% of New Zealand respondents expressed interest in contributing to policy and advocacy work through an interest group. During the year, the College established a New Zealand Advocacy Group bringing together members across specialties and regions to provide feedback on emerging issues and help shape advocacy priorities. The College also continued its Policy and Advocacy Roundup as a regular member update, providing greater visibility of advocacy activity, progress and outcomes. Together, this work strengthened the connection between member expertise, College advocacy and external influence, helping ensure pathology is represented in the decisions that shape the profession, patient care and the broader health system.

New Zealand Committee meeting held in Auckland to discuss the College’s priorities and continued commitment to advocate for pathology across Aotearoa.

21 Return to contents

5. POLICY AND ADVOCACY

Board of Professional Practice and Quality (BPPQ) Throughout 2025–26, the Board of Professional Practice and Quality (BPPQ) continued to provide strategic oversight and advice on professional practice, quality, accreditation, workforce and regulatory matters affecting pathology across Australia and New Zealand. A significant focus was the development of clearer cross-disciplinary supervision arrangements. The BPPQ progressed draft frameworks covering selected chemical pathology, immunopathology and microbiology tests, including QuantiFERON and interferon-gamma release assays. These documents were developed to support consistent supervision decisions and assist NATA in assessing laboratory arrangements. The BPPQ also contributed to the Australian Government’s Better and Faster Access to My Health Record initiative. College advocacy helped ensure that complex reports, including cytopathology, anatomical pathology, genetics and selected haematology results, would retain a delayed-release period, supporting appropriate clinical interpretation and patient communication. Related College guidance on releasing pathology results to patients and consumers was reviewed to reflect the changing requirements. Laboratory safety remained a priority, particularly proposed changes to formaldehyde workplace exposure standards. The BPPQ considered the practical and financial implications for laboratories, exposure concerns

for pregnant Trainees and international approaches to monitoring and risk mitigation. The Board reaffirmed that laboratories and employers must maintain appropriate workplace health and safety controls and referred existing College safety guidance to the Anatomical Pathology Advisory Committee for review. The Board reviewed the College’s guidance on pathologist participation in multidisciplinary team meetings (MDTs), recognising the growing workload associated with MDTs and considerable variation between public and private settings. The BPPQ supported further consultation to ensure the guideline appropriately balances quality patient care, clinical judgement and the effective use of pathologists’ time. The BPPQ maintained oversight of national accreditation developments, including consultation on the consolidated National Pathology Standard and changes affecting clinical scientists and laboratory supervision. Workforce and advocacy discussions included the redesign of the Specialist Training Program (STP), securing continued support for genetic pathology training positions, pathology workforce shortages, training capacity, examination reform and workplace-based assessment. The Board supported advocacy to ensure that funding models recognise pathology’s distinctive service structure, including the essential role of metropolitan laboratories in supporting rural and regional healthcare.

Committee highlights

Academic Advisory Committee

NT State Committee

The Academic Advisory Committee has led the development of the Trans-Tasman Pathology Curriculum in response to concerns about the decline in pathology teaching across university programs. Now in its final stages, the curriculum aims to establish a consistent foundation for pathology education for medical students. The draft has received strong support from medical school leaders and undergone discipline-specific review, with consideration given to Australian Medical Council requirements.

Following its successful revitalisation last year, the Northern Territory Committee is set to become a standalone committee. It previously operated as part of the South Australian State Committee. In April 2026, the Northern Territory welcomed its first forensic pathology Trainee, supported through funding from the Specialist Training Program (STP).

22 RCPA Annual Report 2025-2026

23 Return to contents

6. RCPA PROJECTS

RCPA projects Structured Pathology Reporting of Cancer (SPRC) Project Structured Pathology Reporting of Cancer (SPRC) protocols serve as a vital resource for anatomical pathologists across Australasia, providing benchmark cancer reporting standards essential to clinical practice and a prerequisite for accreditation in Australia. By integrating international guidelines from the International Collaboration on Cancer Reporting (ICCR) and the World Health Organization (WHO) tumour classifications, the SPRC protocols ensure that our practices are aligned with the highest global standards. Grounded in peer-reviewed scientific evidence, this initiative is dedicated to fostering evidence-based, standardised cancer reporting throughout the region. Our ongoing commitment to this project is driven by a singular vision: to support world-class patient care and achieve the best possible outcomes for patients.

SPRC protocols webpages 227,976 downloads 20,872 views

SPRC protocols overview

28 5 1 50 18 4

RCPA SPRC protocol experts engaged Expert committees engaged

New protocol published

New checklists published Cancer protocols in development Checklists in development

Top five most downloaded SPRC protocols 1. Invasive carcinoma of the breast 2. Colorectal cancer 3. Bone marrow 4. Melanoma 5. Thyroid cancer

24 RCPA Annual Report 2025-2026

SPRC digital implementation software trial RCPA was awarded funding (2024–2026) from the Commonwealth Department of Health and Aged Care through the Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program to undertake a multistakeholder software trial, which concluded in June 2026. Trial outcomes and recommendations demonstrated that software-based protocol templates significantly increased histopathology report completeness. The trial established a robust evidence base supporting the transition to automated, machine-readable cancer data reporting – improving data quality, reducing manual extraction costs, and enhancing patient care.

The trial established a robust evidence base supporting the transition to automated, machinereadable cancer data reporting.”

Key trial highlights included: 34 anatomical pathologists from 22 laboratories (55% public, 45% private) completed an evaluation of dedicated digital template reporting platforms. 186 test reports were completed using four Software Trial platforms. 11 clinicians (surgeons, medical oncologists, and radiation oncologists) and nine state and territory cancer registries participated in a comparative survey evaluating control reports against trial software reports and were interviewed on machine-readable pathology report data. High-priority SNOMED CT reference sets were created and published on the RCPA website for six key cancer sites: colorectal,lung, endometrial, ovarian, cervical, and breast cancers.

RCPA Macroscopic Cut-Up Manual The RCPA’s Macroscopic Cut-Up Manual serves as an essential resource for pathologists, registrars and non-pathologist staff, supporting macroscopic dissection in anatomical pathology laboratories.

Webpage analytics 1,112,532 downloads 227,101 views

Updated chapters

3 2

Breast specimens Cervical and vulva

25 Return to contents

6. RCPA PROJECTS

Building capacity in perinatal pathology Stillbirth affects thousands of Australian families each year, and access to high-quality, specialised perinatal investigations can play a critical role in helping families understand why their baby died. Through investment in training, workforce development and collaboration, the RCPA is working to strengthen perinatal pathology services and support the professionals involved in caring for families experiencing perinatal loss. This work has been made possible thanks to funding from the Australian Government Department of Health and Aged Care through our Stillbirth Investigations – Pathologists Project.

Perinatal pathology awards

RCPA perinatal workshop

As part of the RCPA’s commitment to strengthening the pathology workforce, the College continued its perinatal pathology awards program, supporting the development of specialist skills and capacity in perinatal pathology across Australia.

In May, the RCPA brought together perinatal loss coordinators, midwives, anatomical and mortuary scientists, technicians, officers and administrative support staff from across Australia to host a national perinatal workshop.

The program aims to increase the capacity of the pathology profession to undertake perinatal investigations, while also building awareness among prenatal and perinatal care professionals of the availability of specialised stillbirth investigations and autopsies.

Supported through RCPA perinatal awards grants funded by the Department of Health, the workshop provided an opportunity for professionals involved in different aspects of perinatal care to connect, share knowledge and learn from one another. Representatives from each jurisdiction provided an overview of their work, highlighting how funding, geography and workforce capacity can contribute to inequities in the delivery of care.

Between 2022 and 2026, a total of 39 awards were granted to anatomical pathology Fellows, registrars and Trainees, perinatal loss coordinators, scientists and mortuary staff who are employed, or working towards employment, within Australian perinatal pathology services. These included 28 perinatal conference and education awards, six practising perinatal pathology awards and five perinatal travelling fellowship awards.

The workshop created a valuable space for participants to exchange knowledge, experiences and resources, supporting greater continuity of care across the country. It also demonstrated the value of bringing together the broader perinatal care team, with perinatal pathologists, hospitals and health departments recognising the benefits of sharing experiences and comparing processes across departments and jurisdictions. The event marks the beginning of ongoing crossdepartmental and cross-jurisdictional collaboration, helping to strengthen the workforce and improve access to high-quality perinatal care for families throughout Australia.

26 RCPA Annual Report 2025-2026

Prof Jane Dahlstrom OAM The Conversation May 2026

Bringing perinatal pathology into focus In an article published in The Conversation Australia + NZ, Why did my baby die? I’m a pathologist. Here’s what I want you to know, Professor Jane Dahlstrom OAM shared her insights into the vital role of perinatal pathologists in seeking answers for families following stillbirth. Professor Dahlstrom explained how pathologists and multidisciplinary care teams approach stillbirth investigations and the autopsy process. The article offered families greater insight into these investigations and the care and expertise involved in helping determine why a baby died and what this may mean for future pregnancies. By sharing her knowledge with a broader audience, Professor Dahlstrom has helped raise awareness of this important field and the vital work undertaken by perinatal pathologists and care teams in supporting babies and their families through extremely difficult circumstances.

Perinatal pathologists, like myself, aim to uncover the truth and provide answers. There is warmth and kindness behind the work we do, even though sadly death is a constant.” - Prof Jane Dahlstrom OAM, The Conversation

27 Return to contents

7. MEMBERSHIP AND ENGAGEMENT

Membership and engagement The RCPA’s membership and engagement activities reflect the College’s ongoing commitment to supporting members throughout their professional careers. During the year, the College delivered a range of initiatives to facilitate professional development and community engagement, while continuing to strengthen connections across the pathology profession.

Continuing professional development (CPD) CPD requirements

RCPA-endorsed CPD activities

The annual CPD requirements remained unchanged for the 2025 and 2026 CPD cycles. Members are required to complete a minimum of 50 hours across three categories, as well as at least one CPD activity relevant to each of the four levels of CAPE:

RCPA-endorsed CPD activities were introduced in July 2025 to help ease the administrative burden associated with recording CPD for members.

Culturally safe practice

Addressing health inequities

Professionalism

Ethics

Between July and December 2025, 83 unique endorsed activities were made available to members across all CPD categories and covering a range of CAPE requirements. The College continues to identify opportunities to expand the list of recognised endorsed activities available for members.

CPD audit and compliance reporting The annual CPD audit for 2025 CPD was conducted between March and June 2026. Six percent of members in both Australia and New Zealand were selected for audit. Following review, 98.2% of audited members were assessed as having met the CPD requirements. The remaining 1.8% of the members will be required to participate in the 2026 audit. The annual CPD compliance status report of individual members was submitted to Ahpra’s Medical Board of Australia on 30 June 2026.

The Pathology Report podcast The RCPA launched the first season of The Pathology Report, a new podcast series which explores key issues and developments in pathology to provide CPD opportunities for members. Episodes explored a range of topics and themes across the disciplines, with each episode eligible for 30 minutes of CPD and addressing relevant CAPE requirements. Season two is currently being released fortnightly, with recording undertaken at Pathology Update 2026.

28 RCPA Annual Report 2025-2026

RCPA Foundation Grants The RCPA Foundation continued its commitment to advancing pathology through investment in research, education and professional development, awarding $273,000 across nine grants to 13 recipients in 2025.

$35,000 Dr Trung Ngo

Mike and Carole Ralston Travelling Fellowship Award

$25,000

Ms Cindy Pulanco Kanematsu Research Award

$30,000 Dr Iain Abbott Dr Silvia Zheng

RCPA Quality Assurance Programs Research Grant

$10,000

Dr Joshua Li Dr Mark Armstrong Research Grant-in-Aid

$25,000

Dr Hojabr Kakavand Richard Scolyer Research Award

$15,000

Dr Jacklyn Joseph Sullivan Nicolaides Partnership Pathology Scholarship

$25,000

$10,000 Dr Samantha Rowbotham

Dr Ke Li Chow Dr Danielle Robinson Dr Caroline Wong Postgraduate Research Fellowship

Pathology Education Outreach Fellowship

$8000

Dr Bharti Ramnani Bev Rowbotham Pathology Leaders Award

$273,000

Total grants provided

29 Return to contents

7. MEMBERSHIP AND ENGAGEMENT

Connecting the pathology community through events Throughout the year, the RCPA delivered a diverse program of events that brought together Fellows, Trainees, students and the broader pathology community. The College hosted 27 events across multiple locations and online, attracting 2670 attendees, and featuring 331 speakers, with the support of 56 event partners and sponsors.

Hong Kong

Qld

7 NSW

1 SA

Virtual events

Tas

Vic

1 30 RCPA Annual Report 2025-2026

ACT

Events Overview

Total events

2670

Total attendees

331

Total speakers

Total event partners/ sponsors

31 Return to contents

7. MEMBERSHIP AND ENGAGEMENT

Marketing and communications The RCPA’s Marketing and Communications team keeps members informed, promotes the College’s work and priorities, and raises awareness of the vital role of pathology with external audiences. During 2025–26, the team delivered communications across the College’s key activities, including member news, Pathology Today, social media, as well as online communications supporting training, events, advocacy and organisational initiatives. It also coordinated communications from the President and CEO, to provide regular updates to members throughout a year of significant change. In addition, the team supported the College’s advocacy and external engagement, communicating key policy priorities in Australia and Aotearoa New Zealand and supporting media and stakeholder communications. Events, including Pathology Update 2026 and the College’s 70th anniversary celebrations, were promoted through integrated editorial and digital content. A major focus during the year was preparing for the next phase of the College’s digital communications. Work on the new website and CRM included reviewing and restructuring content, developing new approaches to content management and preparing communications for the transition to new digital platforms. Looking ahead, the focus will be on making greater use of these new digital foundations, strengthening content planning and governance, and developing a more coordinated approach to member and external communications.

Website analytics 2,598,985 total views 9207 increase in views

32 RCPA Annual Report 2025-2026

33 Return to contents

7. MEMBERSHIP AND ENGAGEMENT

Pathology RCPA’s peer-reviewed scientific journal Pathology is published six times a year. In addition, the journal publishes an annual special themed issue and the Pathology Update Abstracts supplement.

Journal Impact Factor Pathology achieved a 2025 Impact Factor of 3.9, ranking 16th out of 89 journals in the Pathology category of the Journal Citation Reports (JCR). This strong performance returns the journal to the prestigious Q1 quartile, marking a significant achievement. The result also represents a healthy increase on the 2024 Impact Factor, further reinforcing the journal’s growing influence and standing within the field.

Excluding the exceptional COVID-19 period (2020–2022), during which medical journals worldwide experienced substantial increases in citation performance, this represents the highest Impact Factor and ranking in the journal’s history.

Content and production

RCPA Pathology Article of the Year Award

Pathology is published by Elsevier under a publishing agreement that is currently in the process of being extended from the end of 2026 to the end of 2029. Elsevier provides production, distribution, and marketing services for the journal, as well as expert advice on publishing policy, research integrity, and emerging issues such as the use of artificial intelligence in scholarly publishing. The March 2026 theme issue was ‘Calcium and Bone Metabolism’, edited by Associate Professor Cherie Chiang and Dr Kay Weng Choy.

34 RCPA Annual Report 2025-2026

The Pathology Article of the Year is awarded by the journal’s editors to the most significant eligible manuscript published during the year, in recognition of its outstanding scientific merit. To be eligible, the first author or corresponding author must be an RCPA Fellow, Faculty Member, or Trainee. The 2025 award was presented to co-first authors Christopher McEvoy, Catherine Mitchell, and Owen Prall, together with their colleagues, for the article, ‘The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspective.’

Pathology Editorial Board Clinical Professor John Burnett continued in his third year as Editor-in-Chief, supported by Professor Wendy Cooper as Deputy Editor-in-Chief. A key priority during the year was a comprehensive refresh of the Pathology Editorial Board, with the objective of creating a smaller, more engaged, and productive board. As part of this process, expectations for Editorial Board members were reaffirmed, with members expected to contribute actively through peer review, editorial support, scholarly submissions, and the promotion of the journal. Following this review, 55 Editorial Board appointments were not renewed. As of 30 June 2026, the journal’s editorial leadership comprised 25 Associate Editors and 54 Editorial Board members, serving alongside the Editorin-Chief and Deputy Editor-in-Chief. This streamlined structure is intended to strengthen engagement, accountability, and contribution across the journal’s editorial operations. The journal continued to have a healthy number of submissions across disciplines and from around the world. The Editors use their networks to encourage quality submissions and to build connections both within Australia and globally, which keeps members up to date with research and practice in pathology and gives the RCPA an international presence. The Editors-in-Chief, Associate Editors, members of the journal Editorial Board and reviewers are all volunteers, and their scientific expertise and guidance are vital to the credibility and quality of the journal. The RCPA is grateful for their dedication and time.

Pathology journal metrics

5.0

CiteScore

3.9

Impact factor (rank 16/89)

934

Pages published

646,582 Full text views

Full articles published

Correspondence articles published

312

Peer reviewers

401

Completed peer reviews

355

Pathology Update abstracts published in an online only supplement

35 Return to contents

8. IN RECOGNITION

In recognition RCPA Fellows awarded July 2025 to June 2026 CFM - Clinical Forensic Medicine

Pathology disciplines

Dr Andrew James Dow

PI - Pathology informatics

AP Dr Anubha Aditya

Dr Ryan James Droney

AP - Anatomical pathology

AP Dr Mustafa Aziz Al-Abbasi

Dr Elizabeth Mary Forbes

AP Dr Charlotte Rose Foster

H - Haematology M - Microbiology CP - Chemical pathology I - Immunopathology FP - Forensic pathology GP - Genetic pathology IT - Immunogenetics & transplantation FS - Forensic science

36 RCPA Annual Report 2025-2026

Dr Nisha Sabrina Aloysious

FP Dr Leslie Margaret Anderson

Dr Hamish Timothy Anderson

AP Dr Robert John Fuller

Dr Krista Jiana Appadoo

AP Dr Cian Stuart Gallagher

Dr Win Pa Pa Aung

Dr Hannah Sarah George

Dr Anjana Baskaran

Dr Jeremy Adam Gervasi

Dr Liam Edwin Beiglari

Dr Tran Binh Giang

AP Dr Ruth Helen Bentley

Dr Amanda Yen Lin Goh

Dr Renee Christine Berry

Dr Daniel Soon Lee Goh

AP Dr Sahibinder Singh Bhatti

Dr Earlleen Margaret Gunning

AP Dr William Boneham

Dr Michael Gerald Harrington

Dr Claudia Joan Boshier

Dr Benjamin Lee Hartog

Dr Alexander William Bridges Bowden

Dr Hayley Louise Heaton

Dr Cale Sebastian Burge

Dr Matthew Stanislav Heidecker

Dr Jaimie Lindsay Frazer

AP Dr Rhys Sharp Callander

GP Dr Lawrence Kwan Ki Hui

AP Dr Benjamin William Champion

FP Dr Katherine Ria Hulme

AP Dr Ewan Chan

AP Dr Ali Hikmat Al-Neima Hussein

AP Dr Khalid Jaber

Dr Kelvin Chan

CP Dr Yeuk Ki Cheng

AP Dr Jaimin Choi

AP Dr Mairi Cathleen Jarvis

AP Dr Tzy Harn Chua

AP Dr Ruiyi Jia

AP Dr Zhengyu Samuel Chua

AP Dr Mary John

AP Dr Raviteja Kannekanti

Dr Katherine Leslie Croucher

Dr Matthew Jakab

AP Dr Julien Chakib Dagher

AP Dr Hana Angelia Kawatu

AP Dr Woo Gyeong Kim

Dr Ji Hyun Do

Faculty of Science by Research

AP Dr Chih Kuan

CP Dr Khin Moe Sam

FP Dr Benjamin Jia Wei Kuek

CP Dr Elaine Elizabeth Sanderson

FP Dr Alexandra Jean Kullen

Dr Jessica Din Yee Sia

CP Dr Scott David Bringans

Dr Sam Chi-Sum Lai

Dr Varsha Sivalingam

GP Dr Anna Brown

Dr Edward Charles Lea

AP Dr Hamish Ronald Smith

CP Dr Peter Galettis

CP Dr Amas Kee Hiang Lee

Dr Steven Jordan Smith

AP Dr Won Jae Lee

Dr Christian Stefani

CP Dr Simon Handley

CP Dr Hoi Shan Leung

Dr Georgia Alexandra Gigg Stewart

GP Dr Tom Karagiannis

Dr Tamasine Daniela Stewart

AP Dr Peny Lin

Dr Caitlyn Frances Sun

GP Dr Ella Thompson

AP Dr Shelley Shu-Yu Lin

FP Dr Shi Rui Tan

GP Dr Richard Tothill

Dr Jessica Ling

Dr Li Yun Tan

GP Dr Huiling Xu

Dr Nathanael Christopher Carey Lucas

Dr Helen Michelle Tang

Dr Miles Ma

AP Dr Wan Jing Tay

Dr Michelle Louise Mahony

AP Dr Jo Lin Tee

Dr Hiu Chun Mak

AP Dr Kai Zong Teo

Faculty of Science by Scientific Achievement

Dr Nicholas Lachlan McVilly

AP Dr Myo Thu

GP Dr Pranav Dorwal

Dr Nicholas James Meyer

Dr Tsz Hung Tong

CP Dr Samarina Musaad Ali Musaad

Dr Georgia Virginia Midgley

Dr Matthew Hoyan Tong

AP Dr Emma Moloney

Dr Lap Chi Tsui

CP Dr Shohini Mukerji

Dr Kim Linh Van

Dr Abigail Kegomoditswe Elias

AP Dr Ayesha Mukhtiar

Dr John Raymond Vardanega

Ms Louise Gwenneth Strickland Goddard

GP Dr Krithika Murali

AP Dr Roshni Rebecca Verghese

FS Dr Samantha Kate Rowbotham

AP Dr Reshma Shakya

Dr Linda Lingxu Li

Dr Joanne Sock Hwee Ong

Dr Shin Hnin Wai

AP Dr Ramya Padil

GP Dr Ken Lee Wan

Dr Gianna Maddalena Pastore

AP Dr Joan Kaili Wang

Dr Karrnan Pathmanandavel

AP Dr Annesu Wessels

GP Dr Jennifer Minh Ngoc Phan

AP Dr Christy Elizabeth Punnoose

CP Dr Man Kwan Yip

AP Dr Xinyi Qu

AP Dr Samer Yousef

Dr Thomas Jeffrey Allan Quartermaine

CP Dr Cheuk Yin Stephanie Yu

Dr Norman Park Peng Quek

Dr Wang Ho Yuen

AP Dr Romina Rabbani

Dr Carmen Michelle Yuen

AP Dr James Arthur Rickard

Dr Anil Yasar Zirek

Dr Zainab Ridha

Dr Danielle Hinkley Robinson

Dr Samuel Edwin Robinson

Dr Hoi Ching Wong

Ms Dimitra Beroukas

Dr Georges E.R Grau

Dr Paula Keating

Dr Chik Yan Yip

Faculty of Science by Examination

CP Mr Robin Andrew Williams

Faculty of Science by Pathology Informatics PI

Ms Ying Zhu

Faculty of Clinical Forensic Medicine CFM

Dr Rachel Elizabeth Marr

FP Dr Salona Roopan AP Dr Cody Robert Ross

37 Return to contents

8. IN RECOGNITION

RCPA Awards and Honours RCPA Award Recipients DISTINGUISHED FELLOW AWARDS Dr Clive Cooke OAM

MERITORIOUS SERVICE AWARDS Dr Jeanne Tomlinson

Board of Education and Assessment Prizes

Basic Pathological Sciences Exam Prize Winners

BARBARA WILLIAMS CYTOPATHOLOGY MEMORIAL PRIZE

EDDIE HIRST MEMORIAL PRIZE FOR HIGHEST SCORING AUSTRALIAN BASED TRAINEE

Dr Jack Naughton

DR ANNABELLE MAHAR ANATOMICAL PATHOLOGY TRAINEE MEMORIAL PRIZE Dr Jaimin Choi

KONRAD MULLER OUTSTANDING TEACHING AWARD Dr Poomahal Kumar Dr Amanda Charlton

EVA RAIK HAEMATOLOGY TRAINEE MEMORIAL PRIZE Dr Amanda Yen Lin Goh

Dr Min Gyu Cho

NEIL PRENTICE MEMORIAL PRIZE FOR HIGHEST SCORING NEW ZEALAND BASED TRAINEE Dr Johanna Koevoet Dr Luke Bridgman

TOP-SCORING NON-TRAINEE Dr Anna Antonets

Dr Richard Wong

RCPA SPECIAL SERVICE AWARDS Prof Sunil Lakhani Prof Jurgen Rode

RCPA HONORARY FELLOW AWARDS Prof Sarah Coupland Prof Tony Roscioli

38 RCPA Annual Report 2025-2026

Perinatal Pathology Awards PERINATAL PRACTISING PATHOLOGY AWARD

Australia Day Honours 2025

In memoriam

OFFICER OF THE ORDER OF AUSTRALIA (AO)

Dr Philip Beh Swan-Lip 1958-2025, Late of Hong Kong

Dr Michael Francis Buckley

Dr Hana Kawatu Dr Madeleine McKinley

MEMBER OF THE ORDER OF AUSTRALIA (AM)

Dr Patricia Symons

Dr Barry Denison Lewis Prof Stephen Chiu Ho Li

PERINATAL TRAVELLING FELLOWSHIP AWARD Dr Mitali Fadia

Dr Glenn Begley Prof Minghao Zheng

Dr Victoria Yachmenikova

PERINATAL CONFERENCE AND EDUCATION AWARD Ms Courtney Erbeni Mrs Vicki-Maree Bourke Miss Kamini Pal Dr Eliza Gardner-Brunton Dr Renae Parker

King’s Birthday Honours 2025 COMPANION OF THE ORDER OF AUSTRALIA (AC) Prof William David Rawlinson

Dr Audrey Choy

OFFICER OF THE ORDER OF AUSTRALIA (AO)

Dr Finbarr Coughlan

Prof Jozef Gecz

Dr Michael Chang Dr Ignatius Rudd

MEDAL OF THE ORDER OF AUSTRALIA (OAM) Prof Suran Loshana Fernando

Dr William Edward Lewis Davies 1930-2025, Late of NSW Dr Nicholas Murphy 1978-2025, Late of Tas Dr Cliff Kelland 1939-2025, Late of Tas Dr Lee Price 1963-2026, Late of Qld Dr Joseph Manitta 1948-2026, Late of Vic Dr Boyd Webster 1934-2026, Late of NSW Dr Robert Edwards 1928-2026, Late of SA Prof Richard Scolyer AO 1966-2026, Late of NSW Dr Moira Jean Finlay 1955-2026, Late of Vic

Dr Roger Hampson Dr Noemi Horvath Prof David John Joske Dr Luke Coyle

39 Return to contents

RCPA.EDU.AU Contact us +61 2 8356 5858 rcpa@rcpa.edu.au

Find us Durham Hall, 207 Albion Street Surry Hills NSW 2010 Australia

Connect with us /TheRoyalCollegeOfPathologistsOfAustralasia @the_rcpa /the-royal-college-of-pathologists-of-australasia-rcpa @PathologyRCPA /thercpa.bsky.social @RCPA1954